Myosin Inhibition in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy. Desai MY, Owens A, Geske JB, Wolski K, et al. J Am Coll Cardiol 2022;80:95-108.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Desai MY, Owens A, Geske JB, Wolski K, et al. Myosin Inhibition in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy. J Am Coll Cardiol 2022;80:95-108.
PMID: 35798455